Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacologica… (NCT07681180) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies
Canada60 participantsStarted 2026-08
Plain-language summary
The goal of this prospective pilot study is to learn if the use of virtual reality and/or relaxing soundscapes can help lower anxiety in adult patients undergoing a scheduled coronary angiography or angioplasty as compared to the standard of care. The main questions it aims to answer are:
* The use of non-pharmacological strategies reduces intraprocedural stress and anxiety compared to standard of care
* Reducing anxiety limits the use of pharmacological agents, which increases patient safety.
Researchers will compare the use of relaxing soundscapes or virtual reality to the standard of care to see the effects of these strategies on pain, anxiety and stress.
Participants will:
* listen to relaxing soundscapes, OR experience virtual reality including soundscapes OR standard of care during their procedure,
* Answer pain, anxiety and recovery questionnaires,
* Answer satisfaction questionnaires.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults, 18 years or older
* Scheduled hemodynamic intervention (coronary angiography and/or angioplasty)
* Patient willing and able to understand the study
* Signed informed consent
Exclusion Criteria:
* Scheduled complex procedure (CTO, structural)
* Severe cognitive or psychiatric disorders
* Major hearing/visual impairment
* Severe motion sickness or history of malaise with Virtual Reality (VR)
* Complaints of nausea or vomiting
* History of epilepsy
* Claustrophobia
* Facial injuries
* In clinical isolation (infection control)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in patient-reported anxiety
Timeframe: Baseline (preprocedural), periprocedural and at one-week follow-up
2
Change in patient-reported anxiety
Timeframe: Baseline, Periprocedural, and at one-week follow-up
3
Change in patient-reported pain
Timeframe: Baseline, periprocedural and at one-week follow-up